[1]
S. U. Orhan, F. Bulut, S. Tekin, and M. Ozcan, “Fibroblast growth factor-21: Preserving cell viability in diabetic neuropathy through the AKT/PI3K cellular pathway”, annalsmedres, vol. 31, no. 8, pp. 605–610, Aug. 2024.